4.29
Arbutus Biopharma Corp (ABUS) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
99.43%
1.014
|
179.13 | 1.051 | 0.529 | 10.74 |
| Operating Expenses |
31.71%
6.978
|
10.22 | 6.341 | 9.188 | 9.251 |
| Operating Income/Loss |
103.53%
-5.964
|
168.91 | -5.29 | -8.659 | 1.488 |
| Nonoperating Income/Loss |
4.32%
0.821
|
0.787 | 1.534 | 0.917 | 1.035 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
103.03%
-5.143
|
169.69 | -3.756 | -7.742 | 2.523 |
| Basic Average Shares |
1.91%
197.47
|
193.77 | - | 191.78 | 191.55 |
| Diluted Average Shares |
1.16%
197.47
|
195.21 | - | 191.78 | 192.40 |
| Basic Earnings Per Share |
103.41%
-0.03
|
0.88 | - | -0.04 | 0.01 |
| Diluted Earnings Per Share |
103.45%
-0.03
|
0.87 | - | -0.04 | 0.01 |
大文字化:
|
ボリューム (24 時間):